Effect of Astaxanthin on Cataract Formation Induced by Glucocorticoids in the Chick Embryo

References

• McCarty CA. Cataract in the 21st Century: lessons from previous epidemiological research. Clin Exp Optom 2002;85:91–96
   Google Scholar
• Taylor HR, West SK, Rosenthal FS, Muñoz B, Newland HS, Abbey H, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988;319:1429–1433
   PubMed Web of Science ®Google Scholar
• Hiller R, Giacometti L, Yuen K. Sunlight and cataract: an epidemiologic investigation. Am J Epidemiol 1977;105:450–459
   PubMed Web of Science ®Google Scholar
• Christen WG, Manson JE, Seddon JM, Glynn RJ, Buring JE, Rosner B, et al. A prospective study of cigarette smoking and risk of cataract in men. JAMA 1992;268:989–993
   PubMed Web of Science ®Google Scholar
• West S, Munoz B, Emmett EA, Taylor HR. Cigarette smoking and risk of nuclear cataracts. Arch Ophthalmol 1989;107:1166–1169
   PubMed Web of Science ®Google Scholar
• Hiller R, Sperduto RD, Podgor MJ, Wilson PW, Ferris FL 3rd, Colton T, et al. Cigarette smoking and the risk of development of lens opacities. The Framingham studies. Arch Ophthalmol 1997;115:1113–1118
   PubMed Web of Science ®Google Scholar
• Hankinson SE, Willett WC, Colditz GA, Seddon JM, Rosner B, Speizer FE, et al. A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA 1992;268:994–998
   PubMed Web of Science ®Google Scholar
• Krishnaiah S, Vilas K, Shamanna BR, Rao GN, Thomas R, Balasubramanian D. Smoking and its association with cataract: results of the Andhra Pradesh eye disease study from India. Invest Ophthalmol Vis Sci 2005;46:58–65
   PubMed Web of Science ®Google Scholar
• Kelly SP, Thornton J, Edwards R, Sahu A, Harrison R. Smoking and cataract: review of causal association. J Cataract Refract Surg 2005;31:2395–2404
   PubMed Web of Science ®Google Scholar
• Jacques PF, Chylack LT. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991;53: 352–355
   PubMed Web of Science ®Google Scholar
• Varma SD. Scientific basis for medical therapy of cataracts by antioxidants. Am J Clin Nutr 1991;53:335–345
   Web of Science ®Google Scholar
• Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91:31–38
   PubMed Web of Science ®Google Scholar
• Miki W, Yamaguchi K, Konosu S. Comparison of carotenoids in the ovaries of marine fish and shellfish. Comp Biochem Physiol B 1982;71:7–11
   Google Scholar
• Higuera-Ciapara I, Félix-Valenzuela L, Goycoolea FM. Astaxanthin: a review of its chemistry and applications. Crit Rev Food Sci Nutr 2006;46:185–196
   PubMed Web of Science ®Google Scholar
• Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, Hara A. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res 1995;55:4059–4064
   PubMed Web of Science ®Google Scholar
• Fukuzawa K, Inokami Y, Tokumura A, Terao J, Suzuki A. Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and alpha-tocopherol in liposomes. Lipids 1998;33:751–756
   Google Scholar
• Kobayashi M. In vivo antioxidant role of astaxanthin under oxidative stress in the green alga Haematococcus pluvialis. Appl Microbiol Biotechnol 2000;54:550–555
   PubMed Web of Science ®Google Scholar
• Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 2000;48:1150–1154
   PubMed Web of Science ®Google Scholar
• Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, et al. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci 2003;44:2694–2701
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Ohgami K, Shiratori K, Jin X, llieva L, Koyama Y, et al. Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-κB signaling pathway. Exp Eye Res 2006;82:275–281
   PubMed Web of Science ®Google Scholar
• Lee SJ, Bai SK, Lee KS, Namkoong S, Na HJ, Ha KS, et al. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation. Mol Cells 2003;16:97–105
   PubMed Web of Science ®Google Scholar
• Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol 2003;21:210–216
   PubMed Web of Science ®Google Scholar
• Chew BP, Park JS, Wong MW, Wong TS. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res 1999;19:1849–1853
   PubMed Web of Science ®Google Scholar
• Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, et al. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 2004;20:49–59
   PubMed Web of Science ®Google Scholar
• Krinsky NI. Antioxidant functions of carotenoids. Free Radic Biol Med 1989;7:617–635
   PubMed Web of Science ®Google Scholar
• Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 2000;48:1150–1154
   PubMed Web of Science ®Google Scholar
• Nishigori H, Lee JW, Iwatsuru M. An animal model for cataract research: cataract formation in developing chick embryo by glucocorticoid. Exp Eye Res 1983;36:617–621
   PubMed Web of Science ®Google Scholar
• Nishigori H, Kosano H, Umeda IO, Nishigori H. Inhibition of glucocorticoid-induced cataracts in chick embryos by RU486: a model for studies on the role of glucocorticoids in development. Life Sci 2004;75:3027–3033
   PubMed Web of Science ®Google Scholar
• Lee JW, Iwatsuru M, Nishigori H. Alteration of activities of hepatic antioxidant defence enzymes in developing chick embryos after glucocorticoid administration – a factor to produce some adverse effects? J Pharm Pharmacol 1998;50:655–660
   Google Scholar
• Kosano H, Watanabe H, Nishigori H. Suppressive effects of thyroxine on glucocorticoid (gc)-induced metabolic changes and cataract formation on developing chick embryos. Exp Eye Res 2001;72:643–648
   PubMed Web of Science ®Google Scholar
• Nishigori H, Hayashi R, Lee JW, Maruyama K, Iwatsuru M. Preventive effect of ascorbic acid against glucocorticoid-induced cataract formation of developing chick embryos. Exp Eye Res 1985;40:445–451
   PubMed Web of Science ®Google Scholar
• Murakami I, Kosano H, Ogihara-Umeda I, Nishigori H, Uga S, Ishikawa S. Comparison of lens biochemistry and structure between BSO-treated and glucocorticoid-treated developing chick embryos. Exp Eye Res 1996;63:673–681
   Google Scholar
• Nishigori H, Yasunaga M, Mizumura M, Lee JW, Iwatsuru M. Preventive effects of pyrroloquinoline quinone on formation of cataract and decline of lenticular and hepatic glutathione of developing chick embryo after glucocorticoid treatment. Life Sci 1989;45:593–598
   PubMed Web of Science ®Google Scholar
• Nishigori H, Hayashi R, Lee JW, Iwatsuru M. Effect of MPG on glucocorticoid-induced cataract formation in developing chick embryo. Invest Ophthalmol Vis Sci 1984;25:1051–1055
   PubMed Web of Science ®Google Scholar
• Setogawa T, Kosano H, Ogihara-Umeda I, Kayanuma T, Nishigori H. Preventive effect of SA3443, a novel cyclic disulfide, on glucocorticoid-induced cataract formation of developing chick embryo. Exp Eye Res 1994;58:689–695
   Google Scholar
• Nishigori H, Lee JW, Iwatsuru M. An animal model for cataract research: cataract formation in developing chick embryo by glucocorticoid. Exp Eye Res 1983;36:617–621
   PubMed Web of Science ®Google Scholar
• Lee JW, Iwatsuru M, Nishigori H. Glucocorticoid-induced cataract of developing chick embryo as a screening model for anticataract agents. J Ocul Pharmacol Ther 1995;11:533–541
   PubMed Web of Science ®Google Scholar
• Waagbø R, Hamre K, Bjerkås E, Berge R, Wathne E, Lie O, et al. Cataract formation in Atlantic salmon, Salmo salar L., smolt relative to dietary pro- and antioxidants and lipid level. J Fish Dis 2003;26:213–229
   PubMed Web of Science ®Google Scholar
• Liao JH, Chen CS, Maher TJ, Liu CY, Lin MH, Wu TH, et al. Astaxanthin interacts with selenite and attenuates selenite-induced cataractogenesis. Chem Res Toxicol 2009;22:518–525
   Google Scholar
• Kawada H, Kojima M, Kimura T, Natori S, Sasaki K, Sasaki H. Effect of 5-S-GAD on UV-B-induced cataracts in rats. Jpn J Ophthalmol 2009;53:531–535
   Google Scholar
• Nishigori H, Lee JW, Yamauchi Y, Iwamatsu M. Elevation of glucose in ocular compartments of developing chick embryos with glucocorticoid-induced cataract. Exp Eye Res 1989;49:515–522
   PubMed Web of Science ®Google Scholar
• Watanabe H, Kosano H, Nishigori H. Steroid-induced short term diabetes in chick embryo: reversible effects of insulin on metabolic changes and cataract formation. Invest Ophthalmol Vis Sci 2000;41:1846–1852
   PubMed Web of Science ®Google Scholar
• Bhuvaneswari S, Anuradha CV. Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Can J Physiol Pharmacol 2012;90:1544–1552
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Arai K, Hayashi S, Okamoto H, Takahashi J, Chikuda M, et al. Effects of astaxanthin on antioxidation in human aqueous humor. J Clin Biochem Nutr 2013;53:1–7
   PubMed Web of Science ®Google Scholar
• Sanmartín-Suárez C, Soto-Otero R, Sánchez-Sellero I, Méndez-Álvarez E. Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants. J Pharmacol Toxicol Methods 2011;63:209–215
   PubMed Web of Science ®Google Scholar
• Sørbye H, Guttu K, Gislason H, Grong K, Svanes K. Gastric mucosal injury and associated changes in mucosal blood flow and gastric fluid secretion caused by dimethyl sulfoxide (DMSO) in rats. Dig Dis Sci 1993;38:1243–1250
   PubMedGoogle Scholar